% Generated by roxygen2: do not edit by hand
% Please edit documentation in R/NCA.R
\name{NCA}
\alias{NCA}
\title{Noncompartmental analysis for a dataset with multiple subjects}
\usage{
NCA(Data, colSubj, colTime, colConc, colTrt, Method = "Linear", Dose = 0,
  AdmMode = "Extravascular", TimeInfusion = 0, Report = "Table", iAUC)
}
\arguments{
\item{Data}{name of data table containing time-concentration data of
multiple subjects}

\item{colSubj}{column name for subject ID}

\item{colTime}{column name for the time}

\item{colConc}{column name for the concentration}

\item{colTrt}{column name for the treatment code. This is useful for
crossover study like bioequivalence trial.}

\item{Method}{one of \code{"Linear"} or \code{"Log"} to indicate the way to
calculate AUC}

\item{Dose}{administered dose. One should be careful for the unit. This can
be a vector containing dose for each subject in order.}

\item{AdmMode}{one of \code{"Bolus"} or \code{"Infusion"} or
\code{"Extravascular"} to indicate drug administration mode}

\item{TimeInfusion}{infusion duration for constant infusion, otherwise 0.
This can be a vector containing values for each subject in order.}

\item{Report}{either of \code{"Table"} or \code{"Text"} to specify the type
of return value}

\item{iAUC}{data.frame with three columns, "Name", "Start", "End" to specify
partial interval AUC}
}
\value{
\item{CMAX}{maximum concentration, Cmax} \item{CMAXD}{dose
normalized Cmax, CMAX / Dose, Cmax / Dose} \item{TMAX}{time of maximum
concentration, Tmax} \item{TLAG}{time to observe the first non-zero
concentration, for extravascular administration only} \item{CLST}{last
positive concentration observed, Clast} \item{CLSTP}{last positive
concentration predicted, Clast_pred} \item{TLST}{time of last positive
concentration, Tlast} \item{LAMZHL}{half-life by lambda z, ln(2)/LAMZ}
\item{LAMZ}{lambda_z negative of best fit terminal slope}
\item{LAMZLL}{earliest time for LAMZ} \item{LAMZUL}{last time for LAMZ}
\item{LAMZNPT}{number of points for LAMZ} \item{CORRXY}{correlation of
log(concentration) and time} \item{R2}{R-squared} \item{R2ADJ}{R-squared
adjusted} \item{C0}{back extrapolated concentration at time 0, for bolus
intravascular administration only} \item{AUCLST}{AUC from 0 to TLST}
\item{AUCALL}{AUC using all the given points, including trailing zero
concentrations} \item{AUCIFO}{AUC infinity observed} \item{AUCIFOD}{AUCIFO /
Dose} \item{AUCIFP}{AUC infinity predicted using CLSTP instead of CLST}
\item{AUCIFPD}{AUCIFP / Dose} \item{AUCPEO}{AUC \% extrapolation observed}
\item{AUCPEP}{AUC \% extrapolated for AUCIFP} \item{AUCPBEO}{AUC \% back
extrapolation observed, for bolus IV administration only} \item{AUCPBEP}{AUC
\% back extrapolation predicted with AUCIFP, for bolus IV administration
only} \item{AUMCLST}{AUMC to the TLST} \item{AUMCIFO}{AUMC infinity observed
using CLST} \item{AUMCIFP}{AUMC infinity determined by CLSTP}
\item{AUMCPEO}{AUMC \% extrapolated observed} \item{AUMCPEP}{AUMC \%
extrapolated predicted} \item{MRTIVLST}{mean residence time (MRT) to TLST,
for intravascular administration} \item{MRTIVIFO}{mean residence time (MRT)
infinity using CLST, for intravascular administration} \item{MRTIVIFP}{mean
residence time (MRT) infinity using CLSTP, for intravascular administration}
\item{MRTEVLST}{mean residence time (MRT) to TLST, for extravascular
administration} \item{MRTEVIFO}{mean residence time (MRT) infinity using
CLST, for extravascular administration} \item{MRTEVIFP}{mean residence time
(MRT) infinity using CLSTP, for extravascular administration}
\item{VZO}{volume of distribution determined by LAMZ and AUCIFO, for
intravascular administration} \item{VZP}{volume of distribution determined
by LAMZ and AUCIFP, for intravascular administration} \item{VZFO}{VZO for
extravascular administration, VZO/F, F is bioavailability} \item{VZFP}{VZP
for extravascular administration, VZP/F, F is bioavailability}
\item{CLO}{clearance using AUCIFO, for intravascular administration}
\item{CLP}{clearance using AUCIFP, for intravascular administration}
\item{CLFO}{CLO for extravascular administration, CLO/F, F is
bioavailability} \item{CLFP}{CLP for extravascular administration, CLP/F, F
is bioavailability} \item{VSSO}{volume of distribution at steady state using
CLST, for intravascular administration only} \item{VSSP}{volume of
distribution at stead state using CLSTP, for intravascular administration
only}
}
\description{
conduct noncompartmental analysis for many subjects in a data table
}
\details{
This function calls \code{IndiNCA} repeatedly to do NCA for each subject.
If you specify \code{Report="Text"}, this function returns in free text
format to be used in a report file.
}
\examples{

# Theoph and Indometh data: dose in mg, conc in mg/L, time in h
NCA(Theoph, "Subject", "Time", "conc", Dose=320)
NCA(Indometh, "Subject", "time", "conc", Dose=25, AdmMode="Bolus")

iAUC = data.frame(Name=c("AUC[0-12h]","AUC[0-24h]"), Start=c(0,0), End=c(12,24)) ; iAUC
NCA(Theoph, "Subject", "Time", "conc", Dose=320, iAUC=iAUC)
NCA(Indometh, "Subject", "time", "conc", Dose=25, AdmMode="Bolus", iAUC=iAUC)

writeLines(NCA(Theoph, "Subject", "Time", "conc", Dose=320, Report="Text"),
           "Theoph_Linear_CoreOutput.txt")
writeLines(NCA(Theoph, "Subject", "Time", "conc", Dose=320, Method="Log", Report="Text"),
           "Theoph_Log_CoreOutput.txt")
writeLines(NCA(Indometh, "Subject", "time", "conc", Dose=25, AdmMode="Bolus", Report="Text"),
           "Indometh_Bolus_Linear_CoreOutput.txt")
writeLines(NCA(Indometh, "Subject", "time", "conc", Dose=25, AdmMode="Bolus", Method="Log",
           Report="Text"), "Indometh_Bolus_Log_CoreOutput.txt")
writeLines(NCA(Indometh, "Subject", "time", "conc", Dose=25, AdmMode="Infusion", TimeInfusion=0.25,
           Report="Text"), "Indometh_Infusion_Linear_CoreOutput.txt")
writeLines(NCA(Indometh, "Subject", "time", "conc", Dose=25, AdmMode="Infusion", TimeInfusion=0.25,
           Method="Log", Report="Text"), "Indometh_Infusion_Log_CoreOutput.txt")

}
\author{
Kyun-Seop Bae <k@acr.kr>
}
\references{
\enumerate{ \item Gabrielsson J, Weiner D. Pharmacokinetic and
Pharmacodynamic Data Analysis - Concepts and Applications. 5th ed. 2016.
\item Shargel L, Yu A. Applied Biopharmaceutics and Pharmacokinetics. 7th
ed. 2015.  \item Rowland M, Tozer TN. Clinical Pharmacokinetics and
Pharmacodynamics - Concepts and Applications. 4th ed. 2011. \item Gibaldi M,
Perrier D. Pharmacokinetics. 2nd ed. revised and expanded. 1982. }
}
\seealso{
\code{\link{IndiNCA}}
}
\keyword{NCA}

